Best Hospitals, U.S. News and World Report, National Ranked in 13 specialties - 2014-15

Duke University Hospital: consistently ranked among the nation's best.

AHA Conference Coverage

November 11-15, 2017 | By Christine Welniak

New Research Showcases Duke’s Commitment to Global Cardiology and Care in Kenya

November 14, 2017

New risk models and strategies for care are needed for cardiac disease in pregnant women in East Africa [Read more]


Insights From EXSCEL: A Risk-Modeling Analysis of the Effect of Once-Weekly Exenatide on Cardiovascular Outcomes

November 14, 2017

Does the effectiveness of once-weekly exenatide vary according to a patient’s baseline risk?
[Read more]


Rapid Reversal of Dabigatran in Patients Requiring Emergency Surgery

November 14, 2017

A new analysis of the RE-VERSE AD study shows that idarucizumab achieves normal hemostasis in dabigatran-treated patients needing emergency surgery [Read more]


Racial Disparities Found in Anticoagulation of Atrial Fibrillation Patients in Large Cohort Analysis

November 15, 2017

Large percentages of atrial fibrillation patients with high stroke risk are discharged without anticoagulation [Read more]

Guideline on Ventricular Arrhythmias and Sudden Cardiac Death Prevention Is Updated for the First Time in 11 Years

November 15, 2017

The 2017 guideline includes the first use of value statements as well as recommendations for shared decision making and terminal care [Read more]


Regional Coordination Accelerates Reperfusion Times for Patients With STEMI in Trial Led by Duke and AHA

November 15, 2017

Time to reperfusion matters—faster treatment times can reduce mortality [Read more]


New Tools Are Available for Challenging Cases of Congenital Heart Disease

November 16, 2017

Novel devices are facilitating percutaneous treatment in patients with complex disease [Read more]

Epicardial Injections of Botulinum Toxin Evaluated to Prevent Postoperative Atrial Fibrillation

November 16, 2017

An innovative approach reduced the rate of postoperative atrial fibrillation and the duration of the first episode [Read more]


Mixed Findings From ALLSTAR Trial of Stem Cell Therapy After Myocardial Infarction

November 16, 2017

Patients “matched” for donor-specific antibodies did not reach the primary endpoint—but unmatched patients did [Read more]